Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study.

Source:http://linkedlifedata.com/resource/pubmed/id/7751691

Download in:

View as

General Info

PMID
7751691